Journal of Lipids (Jan 2011)

Obesity, Metabolic Syndrome, and Adipocytes

  • M. V. Dodson,
  • P. S. Mir,
  • G. J. Hausman,
  • L. L. Guan,
  • Min Du,
  • Z. Jiang,
  • M. E. Fernyhough,
  • W. G. Bergen

DOI
https://doi.org/10.1155/2011/721686
Journal volume & issue
Vol. 2011

Abstract

Read online

Obesity and metabolic syndromes are examples whereby excess energy consumption and energy flux disruptions are causative agents of increased fatness. Because other, as yet elucidated, cellular factors may be involved and because potential treatments of these metabolic problems involve systemic agents that are not adipose depot-specific in their actions, should we be thinking of adipose depot-specific (cellular) treatments for these problems? For sure, whether treating obesity or metabolic syndrome, the characteristics of all adipose depot-specific adipocytes and stromal vascular cells should be considered. The focus of this paper is to begin to align metabolic dysfunctions with specific characteristics of adipocytes.